[1]
Al-Agha OM, Axiotis CA. An in-depth look at Leydig cell tumor of the testis. Archives of pathology & laboratory medicine. 2007 Feb:131(2):311-7
[PubMed PMID: 17284120]
[2]
Kim I, Young RH, Scully RE. Leydig cell tumors of the testis. A clinicopathological analysis of 40 cases and review of the literature. The American journal of surgical pathology. 1985 Mar:9(3):177-92
[PubMed PMID: 3993830]
Level 3 (low-level) evidence
[3]
Litchfield K, Thomsen H, Mitchell JS, Sundquist J, Houlston RS, Hemminki K, Turnbull C. Quantifying the heritability of testicular germ cell tumour using both population-based and genomic approaches. Scientific reports. 2015 Sep 9:5():13889. doi: 10.1038/srep13889. Epub 2015 Sep 9
[PubMed PMID: 26349679]
[4]
Accardo G, Vallone G, Esposito D, Barbato F, Renzullo A, Conzo G, Docimo G, Esposito K, Pasquali D. Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients. Asian journal of andrology. 2015 Jan-Feb:17(1):154-8. doi: 10.4103/1008-682X.128514. Epub
[PubMed PMID: 25130577]
[5]
Swerdlow AJ, Schoemaker MJ, Higgins CD, Wright AF, Jacobs PA, UK Clinical Cytogenetics Group. Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. Journal of the National Cancer Institute. 2005 Aug 17:97(16):1204-10
[PubMed PMID: 16106025]
[6]
Powles T, Bower M, Daugaard G, Shamash J, De Ruiter A, Johnson M, Fisher M, Anderson J, Mandalia S, Stebbing J, Nelson M, Gazzard B, Oliver T. Multicenter study of human immunodeficiency virus-related germ cell tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2003 May 15:21(10):1922-7
[PubMed PMID: 12743144]
Level 2 (mid-level) evidence
[7]
Goedert JJ, Purdue MP, McNeel TS, McGlynn KA, Engels EA. Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007 Jun:16(6):1266-9
[PubMed PMID: 17548695]
[8]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: a cancer journal for clinicians. 2016 Jan-Feb:66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7
[PubMed PMID: 26742998]
[9]
Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World journal of urology. 2015 May:33(5):623-31. doi: 10.1007/s00345-014-1361-y. Epub 2014 Jul 17
[PubMed PMID: 25030752]
[10]
McGlynn KA, Cook MB. Etiologic factors in testicular germ-cell tumors. Future oncology (London, England). 2009 Nov:5(9):1389-402. doi: 10.2217/fon.09.116. Epub
[PubMed PMID: 19903067]
[11]
Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. The Journal of pathology. 2003 Jul:200(3):370-4
[PubMed PMID: 12845633]
[12]
Jørgensen A, Lindhardt Johansen M, Juul A, Skakkebaek NE, Main KM, Rajpert-De Meyts E. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development. Seminars in cell & developmental biology. 2015 Sep:45():124-37. doi: 10.1016/j.semcdb.2015.09.013. Epub 2015 Sep 26
[PubMed PMID: 26410164]
[13]
Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, Toppari J, Andersson AM, Eisenberg ML, Jensen TK, Jørgensen N, Swan SH, Sapra KJ, Ziebe S, Priskorn L, Juul A. Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility. Physiological reviews. 2016 Jan:96(1):55-97. doi: 10.1152/physrev.00017.2015. Epub
[PubMed PMID: 26582516]
[14]
Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human reproduction (Oxford, England). 2001 May:16(5):972-8
[PubMed PMID: 11331648]
[15]
Rizzo NM, Sholl LM, Idrees MT, Cheville JC, Gupta S, Cornejo KM, Miyamoto H, Hirsch MS, Collins K, Acosta AM. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2021 Oct:34(10):1935-1946. doi: 10.1038/s41379-021-00845-3. Epub 2021 Jun 8
[PubMed PMID: 34103665]
Level 2 (mid-level) evidence
[16]
Heer R, Jackson MJ, El-Sherif A, Thomas DJ. Twenty-nine Leydig cell tumors: histological features, outcomes and implications for management. International journal of urology : official journal of the Japanese Urological Association. 2010 Oct:17(10):886-9. doi: 10.1111/j.1442-2042.2010.02616.x. Epub
[PubMed PMID: 20812939]
[17]
Di Tonno F, Tavolini IM, Belmonte P, Bertoldin R, Cossaro E, Curti P, D'Incà G, Fandella A, Guaitoli P, Guazzieri S, Mazzariol C, North-Eastern Uro-Oncological Group, Italy. Lessons from 52 patients with leydig cell tumor of the testis: the GUONE (North-Eastern Uro-Oncological Group, Italy) experience. Urologia internationalis. 2009:82(2):152-7. doi: 10.1159/000200790. Epub 2009 Mar 19
[PubMed PMID: 19322000]
[18]
Featherstone JM, Fernando HS, Theaker JM, Simmonds PD, Hayes MC, Mead GM. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease. The Journal of urology. 2009 May:181(5):2090-6; discussion 2096. doi: 10.1016/j.juro.2009.01.038. Epub 2009 Mar 14
[PubMed PMID: 19286222]
[19]
Cheville JC, Sebo TJ, Lager DJ, Bostwick DG, Farrow GM. Leydig cell tumor of the testis: a clinicopathologic, DNA content, and MIB-1 comparison of nonmetastasizing and metastasizing tumors. The American journal of surgical pathology. 1998 Nov:22(11):1361-7
[PubMed PMID: 9808128]
[20]
Dilworth JP, Farrow GM, Oesterling JE. Non-germ cell tumors of testis. Urology. 1991 May:37(5):399-417
[PubMed PMID: 2024387]
[22]
Vallangeon BD, Eble JN, Ulbright TM. Macroscopic sertoli cell nodule: a study of 6 cases that presented as testicular masses. The American journal of surgical pathology. 2010 Dec:34(12):1874-80. doi: 10.1097/PAS.0b013e3181fcab70. Epub
[PubMed PMID: 21107095]
Level 3 (low-level) evidence
[23]
Tetu B, Ro JY, Ayala AG. Large cell calcifying Sertoli cell tumor of the testis. A clinicopathologic, immunohistochemical, and ultrastructural study of two cases. American journal of clinical pathology. 1991 Dec:96(6):717-22
[PubMed PMID: 1746487]
Level 3 (low-level) evidence
[24]
Zukerberg LR, Young RH, Scully RE. Sclerosing Sertoli cell tumor of the testis. A report of 10 cases. The American journal of surgical pathology. 1991 Sep:15(9):829-34
[PubMed PMID: 1719830]
Level 3 (low-level) evidence
[25]
Hanson JA, Ambaye AB. Adult testicular granulosa cell tumor: a review of the literature for clinicopathologic predictors of malignancy. Archives of pathology & laboratory medicine. 2011 Jan:135(1):143-6
[PubMed PMID: 21204721]
[26]
Giannarini G, Mogorovich A, Menchini Fabris F, Morelli G, De Maria M, Manassero F, Loggini B, Pingitore R, Cavazzana A, Selli C. Long-term followup after elective testis sparing surgery for Leydig cell tumors: a single center experience. The Journal of urology. 2007 Sep:178(3 Pt 1):872-6; quiz 1129
[PubMed PMID: 17631320]
[27]
Jimenez-Quintero LP, Ro JY, Zavala-Pompa A, Amin MB, Tetu B, Ordoñez NG, Ayala AG. Granulosa cell tumor of the adult testis: a clinicopathologic study of seven cases and a review of the literature. Human pathology. 1993 Oct:24(10):1120-5
[PubMed PMID: 8406422]
Level 3 (low-level) evidence
[28]
Garrett JE, Cartwright PC, Snow BW, Coffin CM. Cystic testicular lesions in the pediatric population. The Journal of urology. 2000 Mar:163(3):928-36
[PubMed PMID: 10688023]
[29]
Gabrilove JL, Nicolis GL, Mitty HA, Sohval AR. Feminizing interstitial cell tumor of the testis: personal observations and a review of the literature. Cancer. 1975 Apr:35(4):1184-202
[PubMed PMID: 1090360]
[30]
Cornejo KM, Young RH. Adult granulosa cell tumors of the testis: a report of 32 cases. The American journal of surgical pathology. 2014 Sep:38(9):1242-50. doi: 10.1097/PAS.0000000000000216. Epub
[PubMed PMID: 24705318]
Level 3 (low-level) evidence
[31]
Elbachiri M, Taleb A, Derrabi N, Bouchbika Z, Benchakroun N, Jouhadi H, Tawfiq N, Sahraoui S, Benider A. Adult-type granulosa cell tumor of the testis: report of a case and review of literature. The Pan African medical journal. 2017:26():198. doi: 10.11604/pamj.2017.26.198.11523. Epub 2017 Apr 4
[PubMed PMID: 28674591]
Level 3 (low-level) evidence
[32]
Agarwal PK, Palmer JS. Testicular and paratesticular neoplasms in prepubertal males. The Journal of urology. 2006 Sep:176(3):875-81
[PubMed PMID: 16890643]
[33]
Kaplan GW, Cromie WJ, Kelalis PP, Silber I, Tank ES Jr. Gonadal stromal tumors: a report of the Prepubertal Testicular Tumor Registry. The Journal of urology. 1986 Jul:136(1 Pt 2):300-2
[PubMed PMID: 3723681]
[35]
Nonomura K, Koyama T, Kakizaki H, Murakumo M, Shinohara N, Koyanagi T. Testicular-sparing surgery for the prepubertal testicular tumor. Experience of two cases with large cell calcifying Sertoli cell tumors. European urology. 2001 Dec:40(6):699-704
[PubMed PMID: 11805420]
Level 3 (low-level) evidence
[36]
Banerji JS, Odem-Davis K, Wolff EM, Nichols CR, Porter CR. Patterns of Care and Survival Outcomes for Malignant Sex Cord Stromal Testicular Cancer: Results from the National Cancer Data Base. The Journal of urology. 2016 Oct:196(4):1117-22. doi: 10.1016/j.juro.2016.03.143. Epub 2016 Mar 29
[PubMed PMID: 27036305]
[37]
Mortensen MS, Lauritsen J, Gundgaard MG, Agerbæk M, Holm NV, Christensen IJ, von der Maase H, Daugaard G. A nationwide cohort study of stage I seminoma patients followed on a surveillance program. European urology. 2014 Dec:66(6):1172-8. doi: 10.1016/j.eururo.2014.07.001. Epub 2014 Jul 23
[PubMed PMID: 25064686]
[38]
Laclergerie F, Mouillet G, Frontczak A, Balssa L, Eschwege P, Saussine C, Larré S, Cormier L, Vuillemin AT, Kleinclauss F. Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study. World journal of urology. 2018 Mar:36(3):427-433. doi: 10.1007/s00345-017-2151-0. Epub 2017 Dec 11
[PubMed PMID: 29230496]
Level 2 (mid-level) evidence
[39]
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, Nicolai N, Oldenburg J, European Association of Urology. Guidelines on Testicular Cancer: 2015 Update. European urology. 2015 Dec:68(6):1054-68. doi: 10.1016/j.eururo.2015.07.044. Epub 2015 Aug 18
[PubMed PMID: 26297604]
[40]
Bertram KA, Bratloff B, Hodges GF, Davidson H. Treatment of malignant Leydig cell tumor. Cancer. 1991 Nov 15:68(10):2324-9
[PubMed PMID: 1913469]
[41]
Mosharafa AA, Foster RS, Bihrle R, Koch MO, Ulbright TM, Einhorn LH, Donohue JP. Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors? Cancer. 2003 Aug 15:98(4):753-7
[PubMed PMID: 12910519]
[42]
Schwarzman MI, Russo P, Bosl GJ, Whitmore WF Jr. Hormone-secreting metastatic interstitial cell tumor of the testis. The Journal of urology. 1989 Mar:141(3):620-2
[PubMed PMID: 2918605]
[43]
Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 Nov:97():138-144. doi: 10.1016/j.urology.2016.06.066. Epub 2016 Aug 15
[PubMed PMID: 27538802]
[44]
Grogg J, Schneider K, Bode PK, Kranzbühler B, Eberli D, Sulser T, Lorch A, Beyer J, Hermanns T, Fankhauser CD. Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 Patients. The oncologist. 2020 Jul:25(7):585-590. doi: 10.1634/theoncologist.2019-0692. Epub 2020 Feb 11
[PubMed PMID: 32043680]
Level 1 (high-level) evidence
[45]
Conkey DS, Howard GC, Grigor KM, McLaren DB, Kerr GR. Testicular sex cord-stromal tumours: the Edinburgh experience 1988-2002, and a review of the literature. Clinical oncology (Royal College of Radiologists (Great Britain)). 2005 Aug:17(5):322-7
[PubMed PMID: 16097561]
[46]
Azer PC, Braunstein GD. Malignant Leydig cell tumor: objective tumor response to o,p'-DDD. Cancer. 1981 Mar 15:47(6):1251-5
[PubMed PMID: 7226052]
[47]
van der Hem KG, Boven E, van Hennik MB, Pinedo HM. Malignant Leydig cell tumor of the testis in complete remission on o,p'-dichlorodiphenyl-dichloroethane. The Journal of urology. 1992 Oct:148(4):1256-9
[PubMed PMID: 1404649]
[48]
Silberstein JL, Bazzi WM, Vertosick E, Carver BS, Bosl GJ, Feldman DR, Bajorin DF, Motzer RJ, Al-Ahmadie H, Reuter VE, Sheinfeld J. Clinical outcomes of local and metastatic testicular sex cord-stromal tumors. The Journal of urology. 2014 Aug:192(2):415-9. doi: 10.1016/j.juro.2014.01.104. Epub 2014 Feb 8
[PubMed PMID: 24518791]
Level 2 (mid-level) evidence
[49]
Iczkowski KA, Bostwick DG, Roche PC, Cheville JC. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 1998 Aug:11(8):774-9
[PubMed PMID: 9720507]
[50]
McCluggage WG, Shanks JH, Whiteside C, Maxwell P, Banerjee SS, Biggart JD. Immunohistochemical study of testicular sex cord-stromal tumors, including staining with anti-inhibin antibody. The American journal of surgical pathology. 1998 May:22(5):615-9
[PubMed PMID: 9591732]
[51]
Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 is a novel diagnostic marker for testicular germ cell tumors. The American journal of surgical pathology. 2009 Jul:33(7):1065-77. doi: 10.1097/PAS.0b013e3181a13eef. Epub
[PubMed PMID: 19390421]
[52]
Arnesen C, Eich ML, Pena MDCR, Cappel JR, Schwartz L, Rais-Bahrami S, Faraj SF, Prieto Granada C, Gordetsky JB. NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors. The American journal of surgical pathology. 2020 Jan:44(1):61-67. doi: 10.1097/PAS.0000000000001367. Epub
[PubMed PMID: 31498176]
[53]
Grogg JB, Schneider K, Bode PK, Kranzbühler B, Eberli D, Sulser T, Beyer J, Lorch A, Hermanns T, Fankhauser CD. Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data. Journal of cancer research and clinical oncology. 2020 Nov:146(11):2829-2841. doi: 10.1007/s00432-020-03326-3. Epub 2020 Jul 27
[PubMed PMID: 32719989]
Level 2 (mid-level) evidence
[54]
Sun M, Liu Y, Yu J, Diao K, Zhang J, Qiu X, Mi X, Wang J. Mixed granulosa-Sertoli sex cord-stromal tumor of the testis: clinical, ultrasonic and histopathological features: a case report. Translational andrology and urology. 2020 Dec:9(6):2836-2841. doi: 10.21037/tau-20-795. Epub
[PubMed PMID: 33457255]
Level 2 (mid-level) evidence
[55]
Hansen PV, Trykker H, Andersen J, Helkjaer PE. Germ cell function and hormonal status in patients with testicular cancer. Cancer. 1989 Aug 15:64(4):956-61
[PubMed PMID: 2545331]